CARTX news

Latest 1 stories · newest May 26, 2026

CARTX

Cartesian Therapeutics secures loan financing from K2 HealthVentures

Cartesian Therapeutics entered into a Loan and Security Agreement with K2 HealthVentures LLC as lender and administrative agent, dated May 22, 2026. The financing arrangement provides debt capital for the biopharmaceutical company's operations and development activities.

Offering May 26, 2026 sentiment +0.10 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same CARTX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/CARTX/newsSTART FREE